The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 study of abemaciclib combined with chemoimmunotherapy in pediatric and young adult patients with relapsed/refractory neuroblastoma (JPCS Part C).
 
Emily Gustava Greengard
No Relationships to Disclose
 
Melissa Bear
Honoraria - Y-mAbs Therapeutics
 
Bradley DeNardo
No Relationships to Disclose
 
Noah Federman
Stock and Other Ownership Interests - Moderna Therapeutics; Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Tempus
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics
 
Julie Krystal
No Relationships to Disclose
 
Giselle Linda Saulnier Sholler
Consulting or Advisory Role - Illumina; YmAbs Therapeutics Inc
Research Funding - YmAbs Therapeutics Inc
Travel, Accommodations, Expenses - Illumina
 
Yanhong Zhou
Employment - Abbvie; Lilly O.
Stock and Other Ownership Interests - Abbvie; Lilly O.
 
Holly Knoderer
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Sarah C Nabinger
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Lindsey M. Hoffman
Consulting or Advisory Role - Lilly O.